Skip to main content
Top
Published in: BMC Neurology 1/2018

Open Access 01-12-2018 | Research article

Pre-stroke warfarin enhancement of collateralization in acute ischemic stroke: a retrospective study

Authors: Jiaying Zhu, Mengmeng Ma, Yijia Guo, Muke Zhou, Jian Guo, Li He

Published in: BMC Neurology | Issue 1/2018

Login to get access

Abstract

Background

Warfarin therapies not only are used to prevent stroke in patients with high risk of cardioembolism such as patients with atrial fibrillation (AF) and rheumatic heart disease (RHD), but also was associated with lower stroke severity and more favorable functional outcomes in patients with acute ischemic stroke due to middle cerebral artery occlusion. It was speculated that pre-stroke warfarin may promote collateralization and result in reduced stroke severity. This study aimed to investigate the association between pre-stroke warfarin use and leptomeningeal collaterals in patients with acute ischemic stroke due to occlusion of the middle cerebral artery.

Methods

We enrolled consecutive acute ischemic stroke patients (occlusion of the middle cerebral artery within 24 h) with known history of AF and/or RHD at the neurology department of the West China Hospital from May 2011 to April 2017. Computed tomography angiography (CTA) before treatment was used to detect the thrombus. Regional leptomeningeal collateral (rLMC) score based on CTA images was used to assess collateral circulation. Prior use of warfarin was recorded. Univariate and multivariate analyses were performed to detect the association of prior warfarin use with the collateral circulation.

Results

A total of 120 patients were included; 29 (24.2%) were taking warfarin before stroke. The international normalized ratio (INR) in patients with prior warfarin use was 1.53 ± 1.00, compared with 1.02 ± 0.09 in patients without prior warfarin use (P < 0.001). Prior oral warfarin therapy was inversely associated with poor rLMC (OR = 0.07, 95%CI 0.01–0.44, P = 0.005). There were no associations between prior warfarin use and initial stroke severity or functional outcomes at 3 months.

Conclusion

Warfarin use seems improve collateralization in patients with acute stroke. However, clinical controlled studies should be used to verify this claim.
Literature
3.
go back to reference Menon BK, Smith EE, Modi J, Patel SK, Bhatia R, Watson TW, et al. Regional leptomeningeal score on CT angiography predicts clinical and imaging outcomes in patients with acute anterior circulation occlusions. AJNR Am J Neuroradiol. 2011;32(9):1640–5. https://doi.org/10.3174/ajnr.A2564 PubMed PMID: 21799045.CrossRefPubMed Menon BK, Smith EE, Modi J, Patel SK, Bhatia R, Watson TW, et al. Regional leptomeningeal score on CT angiography predicts clinical and imaging outcomes in patients with acute anterior circulation occlusions. AJNR Am J Neuroradiol. 2011;32(9):1640–5. https://​doi.​org/​10.​3174/​ajnr.​A2564 PubMed PMID: 21799045.CrossRefPubMed
12.
go back to reference Tziomalos K, Giampatzis V, Bouziana SD, Spanou M, Kostaki S, Papadopoulou M, et al. Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation. J Thromb Thrombolysis. 2016;41(2):336–42. https://doi.org/10.1007/s11239-015-1262-y PubMed PMID: 26253707.CrossRefPubMed Tziomalos K, Giampatzis V, Bouziana SD, Spanou M, Kostaki S, Papadopoulou M, et al. Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation. J Thromb Thrombolysis. 2016;41(2):336–42. https://​doi.​org/​10.​1007/​s11239-015-1262-y PubMed PMID: 26253707.CrossRefPubMed
13.
15.
go back to reference YM WM, Minematsu K, Yamaguchi T. Effects of anticoagulation on infarct size and clinical outcome in acute cardioembolic stroke. Angiology. 2002;53(5):551–6.CrossRef YM WM, Minematsu K, Yamaguchi T. Effects of anticoagulation on infarct size and clinical outcome in acute cardioembolic stroke. Angiology. 2002;53(5):551–6.CrossRef
16.
go back to reference DeFazio RALS, Morales CL, Levy RV, Dave KR, Lin HW, Abaffy T, Watson BD, Perez-Pinzon MA, Ohanna V. A protocol for characterizing the impact of collateral fl ow after middle cerebral artery occlusion. Transl Stroke Res. 2011;2(1):112–27.CrossRef DeFazio RALS, Morales CL, Levy RV, Dave KR, Lin HW, Abaffy T, Watson BD, Perez-Pinzon MA, Ohanna V. A protocol for characterizing the impact of collateral fl ow after middle cerebral artery occlusion. Transl Stroke Res. 2011;2(1):112–27.CrossRef
19.
go back to reference Pourati IKC, Rand W, Karas RH. Statin use is associated with enhanced collateralization of severely diseased coronary arteries. Am Heart J. 2003;146(5):876–81.CrossRef Pourati IKC, Rand W, Karas RH. Statin use is associated with enhanced collateralization of severely diseased coronary arteries. Am Heart J. 2003;146(5):876–81.CrossRef
21.
go back to reference Chalothorn DFJ. Formation and maturation of the native collateral circulation. J Mol Cell Cardiol. 2010;49:251–9.CrossRef Chalothorn DFJ. Formation and maturation of the native collateral circulation. J Mol Cell Cardiol. 2010;49:251–9.CrossRef
25.
go back to reference Yasaka MMK, Yamaguchi T. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med. 2001;40(12):1183–8.CrossRef Yasaka MMK, Yamaguchi T. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med. 2001;40(12):1183–8.CrossRef
26.
go back to reference Penttilä TLM, Niiranen J, Mehtälä J, Khanfir H, Lassila R, Raatikainen P. Differences in the risk of stroke, bleeding events, and mortality between female and male patients with atrial fibrillation during warfarin therapy. Eur Heart J Cardiovasc Pharmacother. 2018. https://doi.org/10.1093/ehjcvp/pvy026 PubMed Central PMCID: PMCPMID: 30052822. Penttilä TLM, Niiranen J, Mehtälä J, Khanfir H, Lassila R, Raatikainen P. Differences in the risk of stroke, bleeding events, and mortality between female and male patients with atrial fibrillation during warfarin therapy. Eur Heart J Cardiovasc Pharmacother. 2018. https://​doi.​org/​10.​1093/​ehjcvp/​pvy026 PubMed Central PMCID: PMCPMID: 30052822.
28.
go back to reference January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Jr., et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130(23):2071–2104. Epub 2014/04/01. doi: https://doi.org/10.1161/cir.0000000000000040. PubMed PMID: 24682348.CrossRef January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Jr., et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130(23):2071–2104. Epub 2014/04/01. doi: https://​doi.​org/​10.​1161/​cir.​0000000000000040​. PubMed PMID: 24682348.CrossRef
Metadata
Title
Pre-stroke warfarin enhancement of collateralization in acute ischemic stroke: a retrospective study
Authors
Jiaying Zhu
Mengmeng Ma
Yijia Guo
Muke Zhou
Jian Guo
Li He
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2018
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-018-1200-7

Other articles of this Issue 1/2018

BMC Neurology 1/2018 Go to the issue